"Lower generic penetration in Italy, Spain, Portugal and France offers future growth potential as share of generics improves," the company said in an investor presentation.Aurobindo Pharma looks to push deeper into EU, US over next 3-4 years
"Lower generic penetration in Italy, Spain, Portugal and France offers future growth potential as share of generics improves," the company said in an investor presentation.Related Posts:
Gavaskar feels India, Aus players not in right frame of mind for first Test- Pakistan Super League: Younis unsold; Misbah for Islamabad
- De Villiers on top as South Africans dominate MVP rankings
- IPL VIII auction: Yuvraj fetches record price, Delhi break bank
- Abbott's eight wickets helps NSW beat Queensland
0 коммент.:
Отправить комментарий